O
PVLA

OrbiMed’s Palvella Therapeutics PVLA Stock Holding History

OrbiMed’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8M Buy
+134,600
New +$14M 0.37% 61
2018
Q4 		– Sell
-30,699
Closed -$13.8M – 155
2018
Q3 		$13.8M Sell
30,699
-8,551
-22% -$3.72M 0.17% 101
2018
Q2 		$15.9M Sell
39,250
-30,125
-43% -$14.3M 0.19% 100
2018
Q1 		$37.9M Sell
69,375
-21,370
-24% -$13.2M 0.47% 60
2017
Q4 		$54.8M Hold
90,745
– – 0.7% 44
2017
Q3 		$41.8M Hold
90,745
– – 0.4% 67
2017
Q2 		$36.7M Hold
90,745
– – 0.39% 65
2017
Q1 		$18.9M Hold
90,745
– – 0.21% 81
2016
Q4 		$10.2M Hold
90,745
– – 0.13% 92
2016
Q3 		$13.3M Hold
90,745
– – 0.15% 90
2016
Q2 		$11.7M Hold
90,745
– – 0.12% 89
2016
Q1 		$13.8M Hold
90,745
– – 0.15% 73
2015
Q4 		$16.6M Hold
90,745
– – 0.15% 75
2015
Q3 		$13.3M Hold
90,745
– – 0.13% 85
2015
Q2 		$20M Buy
+90,745
New +$20M 0.17% 85

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return